PhaseBio Pharmaceuticals Inc: 8-K filed Sep 27, 2023

Form type

8-K

Filing date

Sep 27, 2023

Accession number

0001169245-23-000050

Filer

PhaseBio Pharmaceuticals Inc (CIK 1169245)